Thirty-eight tumors (five grade I-II astrocytomas, three grade III ast
rocytomas, four glioblastomas, one oligodendroglioma, four ependymomas
, one pineocytoma, three medulloblastomas, four acoustic nerve neurino
mas, one intraspinal neurinoma, one neurofibroma, 10 meningiomas, and
one craniopharyngioma) and three benign lesions of the nervous system
were evaluated cytogenetically after in vitro culture. Sex chromosome
loss was detected in 56% of the cases (-X in 13 of the 25 female patie
nts and -Y in nine of the 16 male patients). The objective of the pres
ent report was to study the role of this abnormality in cells of the n
ervous system.